A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.
Market Scope
Trusted Partner of Industry and Medical Professionals for Ophthalmic Market Research, Primary Research, Independent Perspective, & Objective Analysis
Latest Reports Latest News
Latest Market Reports
Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.
- 341
Comprehensive Pages
- 34
Competitors Profiled
- 11
IOL Categories Forecasted
- 8
Geographic/Economic Breakouts
2023 IOL Market Report: Global Analysis for 2022 to 2028, April, 2023
The “2023 IOL Market Report” provides an in-depth analysis of the current intraocular lens market and forecasts performance over the next five years. It includes analysis of current markets, identification of important trends, and discussion of key factors for future success.
This report describes and forecasts performance by region for 11 categories of IOLs: commodity monofocal, enhanced monofocal/intermediate-optimized monofocal, toric, PC-toric, bifocal, trifocal, extended depth of focus (EDOF), EDOF multifocal hybrid, accommodating, postoperatively adjustable, and phakic IOLs. Additionally, 34 companies are profiled, with discussion of their products, strategic market position, background, and outlook.
Latest Industry News & Trends
6/9/2023
BreakingDry EyeRegulation
Novaliq Gains US Approval of Vevye for the Signs and Symptoms of Dry Eye
Novaliq, of Heidelberg, Germany, reported June 8 that the US FDA had approved Vevye (cyclosporine ophthalmic solution) 0.1% for the treatment of the signs and symptoms of dry eye disease. June 8 wa...
6/9/2023
BreakingRegulation
CorNeat Vision Gains US Clearance for EverPatch Ophthalmic Graft Material
Israel-based CorNeat Vision reported June 8 that the US FDA had cleared itsEverPatch scleral reinforcement patch. The graft is the first synthetic, nondegradable tissue-integrating matrix for use i...
6/9/2023
BreakingDry EyeRegulation
HanAll’s Dry Eye Candidate Tanfanercept Misses Primary Endpoints in Phase III Trial
South Korea-based HanAll Biopharma reported May 19 that its topical anti-inflammatory dry eye candidate tanfanercept missed its primary endpoints in the Phase III VELOS-3 trial. Tanfanercept did no...
6/9/2023
BreakingPharmaceuticalRegulation
Merck Sues US Government Over Medicare Drug Price Negotiation Program
Merck on June 6 sued the US Department ofHealth and Human Services (HHS) over Medicare’s plans to reduce drug prices under the Inflation Reduction Act of 2022, calling the price negotiation process...
6/9/2023
AIBreakingGlaucoma
Researchers Use AI to Find Better Drug Delivery Methods to Treat Glaucoma, Other Eye Disease
Researchers at Johns Hopkins’ Wilmer Eye Institute reported May 24 that they and colleagues from the University of Maryland had used machine learning—a method employed to create artificial intellig...
6/9/2023
BreakingCataractDeals
Sightpath Integrates Another Mobile Business Into Services
Sightpath Medical, of Bloomington, Minnesota, announced June 5 that it would integrate Southern Surgical Support, a Knoxville, Tennessee, mobile cataract services company, into its business. The mo...
6/9/2023
BreakingDealsRetina
BioLight, Alexion Team Up on Diagnosis of Retinal Disease Through Tear Film
Israel’s BioLight Life Sciences and Alexion announced May 30 that they would collaborate on a study of new technology that has the potential to screen the tear film to diagnose retinal disease. The...
6/9/2023
BreakingRefractiveRegulation
US FDA Accepts NDA for Vyluma’s Pediatric Myopia Candidate
Vyluma announced June 6 that the US FDA had accepted its new drug application (NDA) for lead compound NVK002 (low dose atropine 0.01%) for childhood myopia and set a Prescription Drug User Fee Act ...
Physician Surveys
For 20+ years, we have surveyed physicians to provide both physicians & industry professionals unbiased insight into the market.
Complete a Survey
On average, our surveys take only 5 to 15 minutes to complete. Survey results help you analyze practice patterns, evaluate treatment choices, and benchmark your practice.
Benchmark Your Performance
Benchmark reports allow you to gauge your performance, track your practice metrics over time, and compare your practice to national averages.
View Market Insights & Analytics
Additional free data tools include instant survey results, weekly polls, PowerPoint charts, and more.
Learn More Register TodayMarket Scope Methodology
A Multi-Step Approach for Accurate & Timely Data
Proprietary data
- 20+ years of physician survey data
- Disease models
- Cultivated database of physicians, ASCs, and hospitals
- Insight from our team of in-house industry experts
Public data
- Attendance and participation at major, worldwide meetings
- Public health systems and registries
- Clinical study data
- Analysis of company-published financial reports
Over 500 Clients, Large & Small, Have Trusted Market Scope Data & Analysis
Join Market Scope Today
Register A Corporate Account
Register A Clinical Account
A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.